Mumps in Africa: A Scoping Review of 22 Studies from 1994 to 2024

A scoping review compiled evidence on mumps disease and vaccination in Africa, focusing on morbidity, mortality, vaccine safety, and molecular characterization. The review includes 22 relevant studies published between 1994 and 2024, with nearly half published in the most recent period from 2018 to 2024. The document was authored by Irene Gobe and shared on figshare under a CC-BY-NC-ND-4.0 license.

Use Cases

• Assessing mumps seroprevalence and incidence trends in Africa based on the compiled study results.
• Evaluating MMR vaccine safety and considerations for immunocompromised individuals based on the review's findings.
• Investigating evidence for antibody loss and re-vaccination needs in HIV-positive children based on the included studies.
• Analyzing the distribution of research focus areas (e.g., seroprevalence, transmission factors, molecular data) across the 22 studies.

Strengths

• Compiles evidence from 22 relevant studies published over a 30-year period (1994-2024).
• Nearly half (45%; 10/22) of the included studies are from the recent period (2018-2024), indicating current research interest.
• Reports specific seroprevalence ranges, such as 5 to 88.8% in children and over 90% in adults.

Limitations

• The dataset is a 58.3 KB DOCX file, indicating a very limited textual scope rather than primary data.
• Row count and column-level documentation are absent; the document's structure and data semantics must be inferred after download.
• The description is a review summary; the underlying primary data from the 22 studies is not directly accessible.

Provenance

Source

figshare

Collection Method

Systematic search across major databases to identify relevant studies.

Time Range

Studies published between 1994 and 2024.

Freshness

Last updated 2026-04-17 05:20:44; freshness should be verified.

Geography

Africa